SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-15-162203
Filing Date
2015-04-30
Accepted
2015-04-30 16:36:49
Documents
8
Period of Report
2015-06-25
Effectiveness Date
2015-04-30

Document Format Files

Seq Description Document Type Size
1 DEF 14A d895817ddef14a.htm DEF 14A 544820
2 GRAPHIC g895817dsp_031c.jpg GRAPHIC 11722
3 GRAPHIC g895817dsp_060a.jpg GRAPHIC 10575
4 GRAPHIC g895817dsp_060b.jpg GRAPHIC 12793
5 GRAPHIC g895817dsp_060c.jpg GRAPHIC 9305
6 GRAPHIC g895817dsp_060d.jpg GRAPHIC 10200
7 GRAPHIC g895817dsp_061.jpg GRAPHIC 10384
8 GRAPHIC g895817g95p71.jpg GRAPHIC 23317
  Complete submission text file 0001193125-15-162203.txt   668591
Mailing Address 480 ARSENAL ST. BUILDING 1, SUITE 120 WATERTOWN MA 02472
Business Address 480 ARSENAL ST. BUILDING 1, SUITE 120 WATERTOWN MA 02472 617 621 8097
Dicerna Pharmaceuticals Inc (Filer) CIK: 0001399529 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36281 | Film No.: 15819357
SIC: 2834 Pharmaceutical Preparations